New Trend in Weight-Loss Drugs: ‘Casual’ Users
(Getty/Varlay)
Many people trying to shed just a few pounds are turning to GLP-1 medications like Ozempic, Wegovy, and newer options such as retatrutide, even if they are not obese or diabetic. A recent profile by Melissa Dahl in New York magazine highlights a growing trend of “casual” users experimenting with these drugs outside of traditional medical supervision.
These users—predominantly women—are obtaining the medications through med spas, online distributors, and Instagram sellers, then following dosing strategies learned from social media platforms like TikTok and YouTube or from friends. Rather than aiming for dramatic transformations, they often use the injections intermittently, treating them similarly to Botox: a tool to manage weight, self-image, and even mood when their clothing feels tight.
Dr. Jennifer Manne-Goehler of Brigham and Women’s Hospital warns that such self-directed use is not recommended by medical professionals. Still, she notes that some healthcare workers themselves have experimented with personal dosing. Users, for their part, report generally mild side effects, improved lab results, and a sense of relief from the constant mental focus on weight.
Experts caution that the long-term health impacts of this DIY approach remain unclear. Manne-Goehler specifically raises concerns about potential accumulation of visceral fat, which could elevate heart disease risk, particularly when drugs are used in a stop-and-start pattern similar to crash dieting.
This trend underscores both the popularity and the uncertainty surrounding these powerful new weight-loss medications.
About Post Author
